Novartis Ag (NVS) Dividends Paid - Common (2009 - 2026)
Novartis Ag (NVS) posted Dividends Paid - Common of $2.9 billion for Q2 2026, up 15.53% sequentially from $2.5 billion in Q2 2025, and up 15.53% YoY from $2.5 billion in Q2 2025.
Novartis Ag (NVS) Dividends Paid - Common (2009 - 2026) Analysis & Trends
Novartis Ag has reported Dividends Paid - Common for 15 years, with the latest figure at $2.9 billion in Q2 2026.
- Quarterly Dividends Paid - Common rose 15.53% year-over-year to $2.9 billion in Q2 2026, while the trailing twelve-month figure through Jun 2026 was -$4.7 billion (down 240.73% YoY) and the FY2025 annual result came in at $7.8 billion, up 2.54% from the prior year.
- Dividends Paid - Common climbed to $2.9 billion in Q2 2026 per NVS's latest filing, from $2.5 billion in the prior quarter.
- Over five years, Dividends Paid - Common peaked at $10.9 billion in Q2 2023 and troughed at -$7.6 billion in Q4 2024.
- A 5-year average of $1.6 billion and a median of $2.7 billion in 2025 frame the typical range for Dividends Paid - Common.
- The sharpest annual moves came in 2024 and 2025: Dividends Paid - Common slumped 122.2% in 2024, then surged 202.81% in 2025.
- Over 5 years, Dividends Paid - Common stood at $3.6 billion in 2022, then soared by 200.28% to $10.9 billion in 2023, then plunged by 170.04% to -$7.6 billion in 2024, then soared by 132.59% to $2.5 billion in 2025, then grew by 15.53% to $2.9 billion in 2026.
- According to Business Quant data, Dividends Paid - Common over the past three periods registered $2.9 billion, $2.5 billion, and -$7.6 billion for Q2 2026, Q2 2025, and Q4 2024 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Div. Paid (Common) (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 652.20 Bn | 631.44 Bn | 17.26 Bn | 3.23 Bn |
| 2 | AbbVie | 469.51 Bn | 462.94 Bn | 12.70 Bn | 3.07 Bn |
| 3 | Merck | 376.81 Bn | 369.67 Bn | 12.21 Bn | 2.14 Bn |
| 4 | Novartis Ag | 303.04 Bn | 295.35 Bn | 11.24 Bn | 2.87 Bn |
| 5 | Astrazeneca | 257.61 Bn | 252.71 Bn | 12.86 Bn | 6.58 Bn |
| 6 | Amgen | 237.37 Bn | 223.38 Bn | 7.24 Bn | 1.36 Bn |
| 7 | Gilead Sciences | 181.73 Bn | 178.55 Bn | 6.22 Bn | 1.03 Bn |
| 8 | Pfizer | 159.66 Bn | 147.96 Bn | 10.94 Bn | 2.45 Bn |
| 9 | Gsk | 106.24 Bn | 102.07 Bn | 8.24 Bn | - |
| 10 | Sanofi | 55.07 Bn | 47.69 Bn | 10.79 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 2.87 Bn |
| Jun 30, 2026 | 2.87 Bn |
| Jun 30, 2025 | 2.49 Bn |
| Jun 30, 2025 | 2.49 Bn |
| Dec 31, 2024 | -7.62 Bn |
| Dec 31, 2024 | -7.62 Bn |
| Jun 30, 2024 | -2.42 Bn |
| Jun 30, 2024 | -2.42 Bn |
| Jun 30, 2023 | 10.89 Bn |
| Jun 30, 2023 | 10.89 Bn |
| Jun 30, 2022 | 3.63 Bn |
| Jun 30, 2022 | 3.63 Bn |
| Jun 30, 2021 | 5.12 Bn |
| Jun 30, 2021 | 5.12 Bn |
| Jun 30, 2020 | 5.92 Bn |
| Jun 30, 2020 | 5.92 Bn |
| Jun 30, 2019 | 9.99 Bn |
| Jun 30, 2019 | 9.99 Bn |
| Jun 30, 2018 | 12.45 Bn |
| Jun 30, 2018 | 12.45 Bn |